The Journal of Rheumatology


 

Systemic Sclerosis-ILD Management: What Is the Safety/Efficacy of the Cyclophosphamide? Can Duration Increase of ILD Therapy Improve Patients Outcomes?

25 views
February 18, 2021
Comments 0
Login to view comments. Click here to Login